CD274 and neoplasm: BCSS was significantly shorter in RECQL deficient tumors with tumor cell PDL1+ (Fig. 2K, (p =0.0003; HR = 0.73; 95 % CI =0.57-0.94) or PDL1+ TILs (Supplementary Fig. 3A, p <0.0001; HR = 0.26; 95 % CI =0.10-0.65) compared to RECQL proficient PDL1- tumors.